SCHEMBL6977017

SCHEMBL6977017

COc1ccc(OCCCCO)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.53
L3MBTL1 Q9Y468 3/20 0.53
TDP1 Q9NUW8 1/20 0.53
APP P05067 3/20 0.52
MTNR1A P48039 1/20 0.50
MTNR1B P49286 1/20 0.50
DRD2 P14416 1/20 0.50
DRD4 P21917 1/20 0.50
DRD3 P35462 1/20 0.50
KCNH2 Q12809 1/20 0.49
CYP2C9 P11712 1/20 0.48
TSHR P16473 1/20 0.48
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
CA14 Q9ULX7 1/20 0.48
HPGD P15428 2/20 0.47
NPC1 O15118 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15519746 0.98 MAPT (0.51) MAPTL3MBTL1TDP1APPMTNR1A
SCHEMBL8755478 0.98 MAPT (0.51) MAPTL3MBTL1TDP1APPMTNR1A
SCHEMBL1006059 0.98 MAPT (0.51) MAPTL3MBTL1TDP1APPMTNR1A
SCHEMBL9688133 0.98 MAPT (0.51) MAPTL3MBTL1TDP1APPMTNR1A
SCHEMBL970989 0.93 APP (0.53) MAPTL3MBTL1TDP1APPMTNR1A
SCHEMBL1669006 0.92 RARB (0.49) MAPTL3MBTL1TDP1APPMTNR1A
SCHEMBL9808262 0.89 MAPT (0.62) MAPTL3MBTL1TDP1APPMTNR1A
SCHEMBL10731573 0.89 KCNA3 (0.55) L3MBTL1DRD3KCNH2ALDH1A1GAA
Anisole SCHEMBL27795633 0.88 KCNA3 (0.59) MAPTL3MBTL1TDP1DRD2DRD4
SCHEMBL77535 0.86 ALDH1A1 (0.60) MAPTAPPMTNR1AMTNR1BDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0985671-B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP disclosed
US-6476021-B1 Compounds having cGMP-PDE inhibitory effect MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-11-05 US disclosed
US-6197768-B1 THERAPY, PREVENTION ISCHEMIC HEART DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-1048666-A1 NOVEL COMPOUNDS HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-11-02 EP disclosed
EP-0992240-A1 THERAPEUTIC AGENT FOR ERECTION FAILURE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-04-12 EP disclosed
EP-0985671-A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-03-15 EP disclosed
US-6018046-A SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed